Cargando…

Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81

Detalles Bibliográficos
Autores principales: Sarmah, Piyush Bhargav, Ehsanullah, Syed Ali, Sarmah, Bhupendra Dev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033229/
https://www.ncbi.nlm.nih.gov/pubmed/33850372
http://dx.doi.org/10.4103/iju.IJU_590_20
_version_ 1783676370682904576
author Sarmah, Piyush Bhargav
Ehsanullah, Syed Ali
Sarmah, Bhupendra Dev
author_facet Sarmah, Piyush Bhargav
Ehsanullah, Syed Ali
Sarmah, Bhupendra Dev
author_sort Sarmah, Piyush Bhargav
collection PubMed
description
format Online
Article
Text
id pubmed-8033229
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80332292021-04-12 Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81 Sarmah, Piyush Bhargav Ehsanullah, Syed Ali Sarmah, Bhupendra Dev Indian J Urol Letters to Editor Wolters Kluwer - Medknow 2021 2021-01-01 /pmc/articles/PMC8033229/ /pubmed/33850372 http://dx.doi.org/10.4103/iju.IJU_590_20 Text en Copyright: © 2021 Indian Journal of Urology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letters to Editor
Sarmah, Piyush Bhargav
Ehsanullah, Syed Ali
Sarmah, Bhupendra Dev
Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_full Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_fullStr Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_full_unstemmed Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_short Author Reply Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_sort author reply re; sarmah pb, ehsanullah sa, sarmah bd. long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. indian j urol 2020;36:276-81
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033229/
https://www.ncbi.nlm.nih.gov/pubmed/33850372
http://dx.doi.org/10.4103/iju.IJU_590_20
work_keys_str_mv AT sarmahpiyushbhargav authorreplyresarmahpbehsanullahsasarmahbdlongtermfollowupandoutcomesofpercutaneousnephronsparingsurgeryforuppertracturothelialcarcinomaindianjurol20203627681
AT ehsanullahsyedali authorreplyresarmahpbehsanullahsasarmahbdlongtermfollowupandoutcomesofpercutaneousnephronsparingsurgeryforuppertracturothelialcarcinomaindianjurol20203627681
AT sarmahbhupendradev authorreplyresarmahpbehsanullahsasarmahbdlongtermfollowupandoutcomesofpercutaneousnephronsparingsurgeryforuppertracturothelialcarcinomaindianjurol20203627681